Patents Assigned to Epimeron USA, Inc.
  • Publication number: 20240101994
    Abstract: The present disclosure relates to recombinant polypeptides that have olivetolic acid cyclase activity, nucleic acids encoding these recombinant polypeptides, recombinant host cells that produce these recombinant polypeptides, and compositions comprising the recombinant polypeptides, nucleic acids, and/or recombinant host cells. The present disclosure also relates to uses of these recombinant polypeptides, nucleic acids encoding them, and recombinant host cells comprising them, in methods for the preparation of cannabinoids and cannabinoid precursors.
    Type: Application
    Filed: June 20, 2023
    Publication date: March 28, 2024
    Applicants: WILLOW BIOSCIENCES, INC., EPIMERON USA, INC.
    Inventors: Trish CHOUDHARY, Xueyang FENG, Thanh NGUYEN, Matthew WORKENTINE
  • Publication number: 20230340555
    Abstract: The present disclosure provides methods for making glycosylated cannabinoids including methods using recombinant host cells comprising a pathway capable of producing a cannabinoid and a heterologous nucleic acid that encodes a UDP-glycosyl transferase. The disclosure also provides compositions of recombinant host cells capable of producing glycosylated cannabinoids, and compositions and uses of the glycosylated cannabinoids.
    Type: Application
    Filed: May 3, 2023
    Publication date: October 26, 2023
    Applicants: WILLOW BIOSCIENCES, INC., EPIMERON USA, INC.
    Inventors: Mathias Schuetz, Gisele Passaia Prietsch
  • Publication number: 20220186231
    Abstract: The present disclosure provides recombinant host cells comprising a pathway capable of producing a cannabinoid and/or cannabinoid precursor, wherein the pathway comprises an enzyme AAE from a source organism other than Cannabis sativa, such as Humulus lupulus. The disclosure also provides methods of using the host cells to produce rare cannabinoids and/or rare cannabinoid precursors.
    Type: Application
    Filed: December 10, 2021
    Publication date: June 16, 2022
    Applicants: Willow Biosciences, Inc., Epimeron USA, Inc.
    Inventors: Mathias SCHUETZ, Michal PYC